Radiotherapy and Oncology

Article	Citations
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	209
529 Current standard of care treatment in non-metastatic cervix cancer	124
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	124
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	108
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	107
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	97
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	94
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	92
525 Proton and carbon therapy: recent technological advances	90
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	89
45 Stereotactic radiosurgery for tremor: a center experience.	87
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	80
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	78
157 Adaptive radiation therapy	77
480 Addressing the education and training needs of RTT in particle radiation therapy	73
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	71
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	71
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	69
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	68
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	65
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	63
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	63
3429: Modulating innate immunity by DNA damage response inhibition	62
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	62
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	61

749: Reinforcement learning for accelerated automatic treatment planning optimization	60
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	59
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	58
1635: In vivo dosimetry - keeping my finger on the pulse	55
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	55
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	54
1861: Performance of a heart substructures autocontouring tool after clinical implementation	52
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	49
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	48
3201: Dosimetric properties of flexible 3D-printed boluses	47
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	46
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	46
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	46
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	45
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?	44
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	44
760: Dependence on the calibration field in treatment verifications using the 1600SRS liquid array	43
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	43
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	43
1977: PSMA-PET and PCa: an ancillary RADIOSA study beyond a numerical definition of oligometastatic state	43
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	42
1006: Prediction of cisplatin tolerance during chemoradiation in older HNSCC patients: A multicenter study	42
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	42
2116: Outcomes of EBRT and brachytherapy in anal cancer: retrospective analysis between 2016 and 2021	42
2010: Postmastectomy radiotherapy after immediate breast reconstruction: toxicities and control rate.	42
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	42
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	42
2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	41
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	41
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	40
1537: Brachytherapy efficacy and safety in the treatment of primitive tongue carcinomas	40
2026: Quantitative T1 mapping in the presence of an implantable cardiac device on a 1.5T MR-linac	40
1517: Intramedullary and leptomeningeal-epidural metastases. Outcomes of a rare and ominous condition.	40
1651: The impact of ground-glass opacities on dose calculation accuracy for lung SBRT	39
3346: How to balance the patient and clinician needs: Are we on the same side?	39
3484: RAPTOR project: Verification	39
2353: X-irradiation, but not proton, irradiation, induces an inflammatory cytokine response in saliva	39
1136: Electron beam radiotherapy for the management of perianal malignancies	39
2974: Generalised Competing Risk models predict relative risk of cancer events in p16+ oropharynx cancer	36
1317: Identifying Lymphocyte Infiltration for Rectal Cancer Outcome Prediction Using Phase III Trial Data	36
512: Proton minibeam radiation therapy: elucidating in vivo mechanisms with infrared microspectroscopy	36
2874: Interstitial brachytherapy in carcinoma cervix: long term results, toxicity and patterns of failure	36
3548: Virtual patients for clinical trials	36
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	36
1293: Immunotherapy-related hypothyroidism on head and neck cancer: impact of RT dose to the thyroid gland	36
742: EXTREME HYPOFRACTIONATED RT FOR PROSTATE CA. Phase II. Results in toxicity and economical cost	36
972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	35
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	35
3379: Management of older patients with skin cancer: Are we overtreating?	35
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	34

994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	34
692: T1 & T2 mapping on a Unity MRL in a clinically feasible timeframe	34
2011: Physical & psychosocial effects of radical chemoradiotherapy for cervix cancer: a systematic review	34
910: Comparison of Eclipse and RayStation in Multi-Criteria Optimization in Prostate Cancer Radiotherapy	34
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	34
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	33
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	33
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	33
1664: Assessing overall and fractional CTV coverage in breast cancer radiotherapy based on daily imaging	33
2578: Respiratory gating with CPAP in left breast cancer RT: preliminary results of a prospective study	33
1670: Facing the climate change: is radiotherapy as green as we would? A preliminary analysis	32
394: Dosimetric evaluation of synthetic 3DCTs reconstructed from a single x-ray radiograph using CNN	32
527: A novel integrated measure of cervical HDR brachytherapy plan quality	32
262: Radiation induces Mitochondrial Biogenesis and Cellular Quiescence Exit in PDOX models of pHGG	32
1839: Stimulation of immune response to overcome radioresistance in BRCA1 mutant breast cancer cells	32
2889: Risk Assessment of Patient-Specific Quality Assurance Methods for Particle Therapy	32
OFF-PROTOCOL RADIOTHERAPY IN PROSPECTIVE SYSTEMIC THERAPY TRIALS FOR METASTATIC NON-SMALL CELL LUNG CANCER	31
3043: Early response assessment of Ca cervix treated with PETCT based SIB-Online Adaptive Radiotherapy	31
PO-1670 Initial Assessment of Adaptive Pancreas SBRT Treatment Efficiency using ViewRay MRIdian A3i	31
GETTING A HEAD START: REDUCING POST OPERATIVE RADIATION WAIT TIMES IN HEAD AND NECK CANCER	31
Response to the commentary on “Optimizing fractionation schedules for de-escalation radiotherapy in head and neck cancers using deep reinforcement learning” by Mohammad Zahid, and Heiko Enderling	31
OUTCOMES OF BRAIN METASTASIS FROM NON-SEMINOMATOUS GERM CELL TUMOUR: A POPULATION-BASED REVIEW	31
12 Safety and Efficacy of Stereotactic Body Radiotherapy for Ultra-Central Thoracic Tumours	30
304 the Changing Landscape of Radiation Therapy: Implications for Future Planning	30
OC-0267 Long-term results of an SBRT dose-escalation trial for bone and lymph node metastases (NCT03486431)	30
109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials	30
Efficacy and toxicity of hyperfractionated thoracic reirradiation	30
174: Influence of Palliative Radiotherapy on Toxicity and Survival in Patients Treated with Radium-223 Dichloride for Metastatic Castrate-Resistant Prostate Cancer	29
SP-0035 From atlas-based knowledge to ML-based planning solutions	29
PO-1886 Respiratory motion prediction based on LSTM and linear regression models	29
PO-1488 Local recurrence of prostate cancer after curative RT: the role of salvage SBRT re-irradiation	29
OC-0775 Comprehensive proton dose prediction with Bayesian LSTMs	29
73: Erectile Function After 60 GY in 20 Fractions External Beam Radiotherapy to the Prostate	29
OC-0766 Gain from respiratory gating in left-sided partial breast irradiation in the DBCG PBI trial	29
MO-0789 Patient experience of head and neck treatment on a 1.5T MRLinac: is our adaptive solution tolerable?	28
67: Ensuring Superior Reporting of Non-Inferiority Radiotherapy Clinical Trials: A Systematic Review	28
PO-1632 deep learning-based automatic segmentation of rectal tumors in endoscopy images	28
PO-1542 Seminal vesicle displacement with Hydrogel spacer insertion on prostate radiotherapy	28
PD-0231 Acute toxicity after the 5-fraction versus 15-fraction radiotherapy regimen for early breast cancer	28
PO-1589 Clinical outcomes of two radiotherapy schedules for spinal cord compression	28
MO-0725 Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology imageS	28
PO-1344 Prognostic significance of platelet-to-lymphocyte ratio in hepatocellular carcinoma	27
PO-2353 Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer	27
PO-1893 Gated dynamic trajectory radiotherapy: feasibility, mechanical accuracy and dosimetric validation	27
SP-0016 Dopamine receptor antagonists, radiation, and cholesterol biosynthesis in mouse models of glioblastoma	27
PO-1640 MRI-based deep learning autocontouring: Evaluation and implementation for brain radiotherapy	27
PO-1406 Re-irradiation in locally recurrent rectal cancer: a national survey of the AIRO GI study group	27
PO-1938 Organ motion in thorax and abdomen during radiotherapy: a multicenter study in 188 children	27
PO-1914 Surface Guided Helical Tomotherapy for Total Marrow Irradiation	27
MO-0148 Time trends for online adapative treatment on the 1.5T MR-Linac	26
PO-2225 Characterization of the RBE of various photon radiation qualities on human cancer cell lines	26
PO-2166 Commissioning of new rectal applicator using electronic brachytherapy source	26
PO-1350 Quality of life changes in esophageal cancer patients treated with preoperative or Radical ChemoRT	26
OC-0437 Mature outcomes for TROG 99.03: RCT of RT +/- (R)-CVP in Stage I-II Follicular Lymphoma	26
PO-1964 Towards a novel treatment plan evaluation concept in carbon ion radiotherapy based on high-LET-dose	26
PO-1386 Treatment outcomes of 1.5 T MR-guided adaptive radiotherapy for locally advanced pancreatic cancer	26
PD-0418 Interstitial And Surface Mold Brachytherapy For Head And Neck Cancers- An Institutional Experience	26
PD-0805 Inter-observer variation for national Danish contouring atlas on organs at risk in the pelvis	25
OC-0449 Deep learning based NTCP-modelling using 3D-information for predicting late xerostomia	25
MO-0481 Towards near real-time adaptive proton therapy: the partial adaptation strategy	25
OC-0592 Patient reported quality of life during and after primary radiotherapy for prostate cancer	25
OC-0436 A Delphi consensus study on SBRT for oligometastatic renal cell carcinoma (RCC) an ESTRO ACROP study	25
PO-2282 SABR Prostate: A review of specialised techniques for motion management	25
SP-1017 Proton arc therapy: Rationale and current status	25
OC-0466 Verification of rectal cancer target auto-contouring by trained RTTs in online adaptive MRIgRT	25
PO-1281 External validation of the MSKCC nomogram for Ductal Carcinoma in Situ and risk factors analysis	25
OC-0122 Deep Learning Segmentation of Cardiac Substructures in Radiotherapy Planning	24
PO-2038 Analysis of daily treatment fractions using PerFRACTION on a Halcyon linac	24
PO-1694 MRI derived brain morphometric measurements: effect of voxel size, anisotropy and slice orientation	24
MO-0390 Evaluating intra-breath-hold variation in IMAT breast boost patients delivered in DIBH	24
SP-1034 Oligometastatic renal cell carcinoma	24
MO-0881 Evaluation of plan-of-the-day selection in adaptive radiation therapy of cervical cancer	24
PO-2130 clinical outcomes of brachytherapy combined with applicator-guided IMRT in bulky cervical tumor	24
OC-0942 Geometric stability during Stereotactic Arrhythmia Radiotherapy	23
PD-0401 The effect of dose to the brain on early self-reported neurocognition; does low dose matter?	23
OC-0254 Feasibility of RTT-only Conebeam CT-guided online adaptive radiotherapy for bladder cancer	23
PO-1131 Proton and carbon ion therapy for intracranial meningioma after previous brain radiotherapy	23
261 A 3D Star Shot to Determine Axes of Rotation	23
PD-0248 Can surface imaging predict the impact of anatomical deformations on proton breast treatment?	23
PD-0250 Intrafraction tumor motion monitoring and dose reconstruction for liver spot scanning proton therapy	23

MO-0951 Outcome of total body irradiation for hematopoietic stem cell transplantation conditioning	23
33 Efficacy of Ultra Hypofrationed Radiotherapy Combined with HDR Brachytherapy	23
OC-0119 Interactive deep-learning for tumour segmentation in head and neck cancer radiotherapy	23
PD-0398 Clinical outcomes of Thyroid Sparing Radical Chemoradiation in the treatment of Head and Neck cancer	23
PO-2245 In situ abscopal effect: synergistic efficacy of immunotherapy and partial tumor irradiation	23
OC-0933 Automatically Triggered Surface-Based RT in DIBH in Breast Cancer - SAVE HEART dosimetry report	23
206 Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non-Operative Patients or Salvaging Local Failure	23
PD-0663 Deep learning cycleGAN MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers	22
SP-0356 Low dose radiotherapy reverses resistance to immunotherapy: From bench to bedside	22
SP-0336 Spatially-fractionated radiotherapy: Tumour-subvolumes, dose-delivery and clinical applications	22
PO-1193 Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study	22
PO-1247 Safety of CDKI combined with radiotherapy in hormone receptor positive breast cancer	22
126 Investigation of a Monte Carlo Model Based Dose Calculation for 103Pd Low Dose Rate Breast Brachytherapy	22
PD-0253 Ultra-compact and highly efficient proton therapy: Design considerations and clinical simulations	22
133: Interventions to Support Nutrition in Patients Undergoing Concurrent Chemoradiation for Esophageal Cancer: A Systematic Review of Randomized Trials	22
Moderate adverse events and regional differences in CDK4/6 inhibitor treatment combined with palliative radiotherapy	22
247 the Effect of CT Acquisition Parameters on Extracted Radiomic Features Using Computational Phantoms	22
Need for standardization in the use of structures in the intensity-modulated radiation therapy planning of head and neck cancers, a GORTEC study	22
PD-0962 Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC.	21
Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model	21
123 Can machine-learning model predict overall survival in head and neck cancer patients?	21
Radiation therapy for stage IIA/IIB seminomas: Back to the future?	21
PO-1532 Long-term outcomes of proton beam therapy for elderly patients with prostate cancer	21
78 Targeting tumor-promoting myeloid cell functions in head & neck cancer	21
161 14-day Pathway from Decision to Treat to Radiotherapy for Head and Neck Cancer in the National Health Service: An Evaluation of Feasibility and Outcomes at Torbay Hospital.	21
179 Contralateral Neck Recurrence Following Unilateral Treatment for Oral Tongue Squamous Cell Carcinoma	21
230 Body image seen by patients with nasopharyngeal cancer	20
239 Re-irradiation in head and neck cancers: Real-world experience from a tertiary cancer institute	20
3394 Use of a compression belt as a cost-effective means for reducing lung tumour motion for SBRT treatment	20
4161 Capsaicin Patch Therapy for Chronic Neuropathic Pain in Breast Cancer Survivors: Importance of Early Diagnosis and Intervention	20
2426 Evaluation of an AI-based autosegmentation software for head and neck vessels contouring	20
94 Influence of chemotherapy regimens prior to nivolumab on the survival of recurrent/metastatic SCCHN.	20
121 Differential functional outcomes following transoral surgery for oropharyngeal carcinoma -laser versus robot	20
244 The volumetric and dosimetric impacts of respiratory motion management in lung SBRT: A systematic review	20
4208 THE VALUE OF COMPLETE RESPONSE IN OLIGOMETASTASIS-DIRECTED SBRT FOR PROSTATE CANCER: A MONOINSTITUTIONAL EXPERIENCE	20
130 head and neck rhabdomyosarcoma; clinicopathological features, trends, and role of adjuvant therapy.	20
3574 First institutional report from Argentina on stereotactic body radiotherapy (SBRT) in patients with oligometastatic gynecologic cancer	20
2418 Bias in radiation therapy publications	20
4581 Remote Dose Rate Assessment for FLASH Quality Assurance	20
4262 Internal Audit of Palliative Radiotherapy Protocols: Impact of Fractionation and 30-Day Mortality Outcomes in Advanced Cancer Patients	19
4863 How to (critically) read a paper?	19
769 Management of head and neck squamous cell carcinoma with N3 nodal disease	19
946 Creating a SPACE for Prostate SBRT- a Single Institution’s Pilot Study	19
4270 Accidental Discovery of a Unique High-Density Bolus Property Enabling Single-Step Bolus Alignment and Patient Positioning in SGRT	19
4695 Challenges and opportunities of biomarker-directed optimisation of breast radiotherapy	19
685 Quality-of-life and in-depth pain-response after stereotactic ablative radiotherapy of oligometastatic bone metastases in the BONY-M trial	19
67 Comparative analysis of 3DCRT, IMRT and Helical Tomotherapy in Glioblastoma: Evaluation of recurrence dynamics	19
873 Operable breast cancer patients who refuse surgery can be cured by definitive radiotherapy with or without radiosensitization strategy	19
4684 The next frontier with (VHE)E	19
4749 Evolving practice: How re-irradiation is shaping the role of the RTT	19
471 Quality of Life after post mastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year followup results of a prospective randomised trial.	19
872 A systematic review of pragmatic randomized controlled trials in oncology	19
657 Breaking Barriers: Patient-related factors impacting upon radiotherapy clinical trial enrolment	19
4932 ALK-driven NSCLC and radiotherapy - pro	18
3276 Time Analysis of Proton Therapy Treatment Delivery for Workflow Optimization	18
3857 systematic literature review of particle therapy costing literature: a 20-years overview	18
3744 Feasibility of nipple-areola complex preservation in retroareolar disease: oncological outcomes and therapeutic implications	18
3792 Feasibility and accuracy of patient setup in gynaecological cancer treatments using Surface-Guided Radiotherapy	18
2109 Real-world clinical outcomes of stereotactic MR-guided adaptive radiotherapy (SMART) for localized pancreatic cancer: A retrospective cohort analysis	18
2330 An evaluation of the first advanced practice RTT in Hong Kong: specialist radiation therapist in uro-oncology	18
259 Repeat SABR likely required for survival benefit in oligometastatic colorectal cancer: results from the prospective randomised SABR-SCAN trial	18
3903 Association between severe adverse events and organ-at-risk dose in Stereotactic Arrhythmia Radiotherapy: a mid-term safety evaluation	18
3817 Predicting IROC’s Thoracic Dosimetry Audit Performance Using Random Forest Modeling and Feature Interpretability.	18
3293 Reduced CTV-to-PTV margins for online adaptive radiotherapy for prostate cancer	18
4928 Dose accumulation in radiotherapy of skin cancer	18
2074 Clinical safety and efficacy of palliative Simultaneous Integrated Boost Lattice RT in patients with advanced cancers: A prospective analysis	18
2358 Integrating novel and classical prognostic factors in locally advanced cervical cancer: a machine learningbased predictive model (ESTHER Study).	18
2677 Automated proton therapy treatment planning pipeline for head and neck cancer patients	18
3877 A Deep Learning-Based Predictive Model: Can AI Accurately Predict VMAT Dose Distributions in Lung Cancer?	18
3604 Artificial Intelligence-driven failure prediction on TomoTherapy® systems	18
3885 Patient specific 4D photon dose reconstruction and accumulation based on treatment log files : a framework for adaptive radiotherapy assessment	18
1939 Online 2D dose verification required in UHDR-FLASH preclinical research: challenges and possibilities	18
2297 Elective nodal CTV in early anal cancer: A systematic review and meta-analysis on the risk of recurrence in the upper pelvic and external iliac LNS	18
2588 Impact of pain education on pain relief in oncological patients: an AMSTAR-compliant systematic review of systematic reviews and meta-analyses.	18
1419 Open or closed: a prospective, self-controlled study of the performance of two immobilisation mask types in head and neck cancer radiotherapy	17
1456 Clinical priorities-driven head and neck simultaneous integrated boost radiotherapy using deep reinforcement learning	17
4338 APRT Analysis for Online Adaptive Radiotherapy Contouring and Adaptor Model Evaluations Using Time-Driven Activity-Based Costing	17
4538 Adult survivors of childhood cancers: own experience	17
2899 Frame induced MR distortion in Gamma Knife radiosurgery: assessment at 1.5T and 3T for two frame models	17
3170 Hypoxia region dose escalation in head and neck cancer – dosimetric analysis	17
1026 SABR for high and very-high risk prostate cancer: early insights into feasibility and safety	17
1414 PERSONAL - Personalized extended-interval fractionated SBRT using online adaptive planning: enhancing efficacy and tolerability in metastatic patients	17
1366 Assessing the Predictive Role of Volumetric Changes in Soft Tissue Sarcomas of the Extremities Following Neoadjuvant Radiotherapy	17
4411 Hypofractionated radiotherapy for breast cancer after mastectomy : can dosimetric constraints be achieved?	17
447 IMRT by Tomotherapy with concurrent weekly cisplatin followed by Brachytherapy HDR in locally advance cervical cancer (prospective study).	17
2925 Optimization of External Contours in Eclipse for Surface-Guided Radiotherapy with Exactrac Dynamic	17
3223 Prognostic Impact of Lymph Node Ratio in Locally Advanced Oral Cancer Patients: Insights from a Randomized Trial Subgroup (NCT00193843)	17
1242 Attention-based vision classifier to predict late radiation toxicity from MR images acquired early after radiotherapy of a murine model	17
1300 High-risk localized prostate cancer treated with risk-adapted intensification therapy: Clinical impact of radiation dose	17
1464 Tumour Response Assessment with PSMA-PET Scan (PSMA Scan) Following Stereotactic Ablative Body Radiotherapy (SABR) for Renal Cell Carcinoma (RCC)	17
4441 Bowel function assessed using Patient Reported Outcome Measures after contact brachytherapy for rectal cancer within the CITRuS trial	17
4567 Radonek - Fine-Tuned GPT-4o for Radiation Oncology Patient Support: Preliminary Evaluation and Protocol for Prospective Validation	17
2738 Abdominal Compression vs Non-Abdominal Compression Planning CT for Cardiac Stereotactic Ablative Radiotherapy (cSABR)	17
3001 Advanced MRI Perfusion Biomarkers for Predicting Relapse Sites in Grade 4 IDH-Mutant Astrocytoma and Glioblastoma	17
1117 Association between Tumor Regression during Radiotherapy and Survival in Lung Cancer: A Systematic Review and Meta-Analysis	17